by European Public Health Alliance | Apr 6, 2020 | Opinion
Download the article How will pharma price the products against COVID-19, be they anti-viral therapies and/or a vaccine? As the pandemic hits Europe and the U.S., pharma is firmly in the spotlight as society turns to them hoping that some therapeutics will be...
by European Public Health Alliance | Mar 25, 2020 | Statements
EPHA joined 61 organisations including patients, consumers, healthcare professionals, trade unions and public interest organisations in expressing our views on the importance of the role of public support to research and development during the current pandemic. Since...
by European Public Health Alliance | Feb 6, 2020 | Opinion
2020 is a special year for the EU policy world. During the second half of last year, we heard a lot about the overarching themes of the von der Leyen Commission. For the next eleven months, there will be a lot of pushing and turning – and lobbying money spent- to zoom...
by European Public Health Alliance | Dec 28, 2019 | Position & Policy Papers
Download the analysis The intergovernmental regional initiatives of collaboration around access to medicines policy are here to stay. Zooming in on the BeNeLuxA coalition, the most advanced of the regional European clusters (henceforth the regionals), this reflection...
by EPHA | Dec 19, 2019 | Statements
Joint open letter on access to clinical study reports EMA’s transparency and access to documents policy should not be watered down: instead it deserves greater attention as it is a cornerstone for enlightened research and decision making, public scrutiny and trust in...
